The Impact of Prior Authorization on Buprenorphine Dose, Relapse Rates, and Cost for Massachusetts Medicaid Beneficiaries with Opioid Dependence

OBJECTIVE: To assess the impact of a 2008 dose-based prior authorization policy for Massachusetts Medicaid beneficiaries using buprenorphine + naloxone for opioid addiction treatment. Doses higher than 16 mg required progressively more frequent authorizations. DATA SOURCES: Mediciaid claims for 2007...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Serv Res
Main Authors: Clark, Robin E, Baxter, Jeffrey D, Barton, Bruce A, Aweh, Gideon, O'Connell, Elizabeth, Fisher, William H
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Pricing and Payment Policies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4237648/
https://ncbi.nlm.nih.gov/pubmed/25040021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1475-6773.12201
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados